Trastuzumab,Tucatinib
Seagen,Roche
[]
 here s the famous waterfall plot &amp; #tweetorial. ~2 year overall survival in refractory metastatic setting is the finding with an easy regimen with no crazy issues. win win: efficacy &amp; qol standpoint. we have a poster on #her2 concordance. #gi23 
Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼‍🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO📍 #GI23